Rawcliffe Adrian - Insider Non-Derivative Transactions at Adaptimmune Therapeutics PLC (ADAP) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jan 17, 2024, Rawcliffe Adrian's relationship to Adaptimmune Therapeutics PLC (ADAP) is Director,Officer (Chief Executive Officer), and currently has 44,848 shares of American Depositary Shares representing Ordinary Shares.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ADAP insiders.

Data Source: SEC.
Rawcliffe Adrian - Insider Non-Derivative Transactions of ADAP American Depositary Shares representing Ordinary Shares
Rawcliffe Adrian - Insider Non-Derivative Transactions at ADAP
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jan 18, 2024 Sell -- (American Depositary Shares representing Ordinary Shares) 30080 0.67 44848
Jan 17, 2024 Sell -- (American Depositary Shares representing Ordinary Shares) 9304 0.79 14104
Jan 13, 2024 Sell -- (American Depositary Shares representing Ordinary Shares) 17257 0.85 26388
Jan 12, 2024 Sell -- (American Depositary Shares representing Ordinary Shares) 11945 0.84 18395
Sep 2, 2023 Sell -- (American Depositary Shares representing Ordinary Shares) 2403 0.78 3449
Jun 28, 2023 Sell -- (American Depositary Shares representing Ordinary Shares) 2333 0.92 3519
Jan 18, 2023 Sell -- (American Depositary Shares representing Ordinary Shares) 10057 1.86 13351
Jan 13, 2023 Sell -- (American Depositary Shares representing Ordinary Shares) 18763 1.71 24882
Jan 12, 2023 Sell -- (American Depositary Shares representing Ordinary Shares) 13042 1.75 17298
Jan 5, 2023 Sell -- (American Depositary Shares representing Ordinary Shares) 5073 1.69 6631